Showing results 4 to 5 of 5
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Phase 3 study of first-line crizotinib vs pemetrexed−cisplatin/carboplatin in East Asian patients with ALK+ advanced non-squamous non-small cell lung cancer (NSCLC) Proceeding/Conference:Journal of Clinical Oncology | 2016 | ||
2018 |